Arteris (AIP) Research & Development (2020 - 2026)

Arteris (AIP) has 6 years of Research & Development data on file, last reported at $8.5 million in Q1 2026.

• Quarterly Research & Development rose 30.65% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.6 million (up 23.48% YoY) and the FY2025 annual result came in at $26.8 million, down 40.49% from the prior year.
• Research & Development improved to $8.5 million in Q1 2026, from $7.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $12.2 million in Q2 2025 to a low of $3.9 million in Q1 2022.
• A 4-year average of $7.1 million and a median of $6.7 million in 2025 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 142.79% in 2025, down 38.71% in 2025.
• Tracing AIP's Research & Development over 4 years: stood at $4.5 million in 2022, then surged by 158.8% to $11.5 million in 2024, then plunged by 38.71% to $7.1 million in 2025, then gained by 20.68% to $8.5 million in 2026.
• The last three Research & Development figures came in at $8.5 million (Q1 2026), $7.1 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.